{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:56:40Z","timestamp":1790891800430,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2024ZD0522400"],"award-info":[{"award-number":["2024ZD0522400"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330070"],"award-info":[{"award-number":["82330070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2511099"],"award-info":[{"award-number":["W2511099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["202101070007-E00097"],"award-info":[{"award-number":["202101070007-E00097"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pccm.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:22:22Z","timestamp":1789039342000},"page":"219-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatable traits-based management of bronchiectasis: moving from theory to clinical practice"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0664-2974","authenticated-orcid":false,"given":"Guiyin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-8973","authenticated-orcid":false,"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pccm.2026.08.004_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"Ara\u00fajo","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/rccm.201903-0604PP","article-title":"Clinical fingerprinting: a way to address the complexity and heterogeneity of bronchiectasis in practice","volume":"201","author":"Martinez-Garcia","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pccm.2026.08.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0108-2018","article-title":"A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults","volume":"28","author":"Crichton","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits down under international workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0007","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(17)31448-4","article-title":"Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993-2012)","volume":"390","author":"Ebmeier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.pccm.2026.08.004_bib0008","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pccm.2026.08.004_bib0009","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","article-title":"Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management","volume":"400","author":"Gorman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.pccm.2026.08.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01126-2025","article-title":"European Respiratory Society clinical practice guideline for the management of adult bronchiectasis","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0012","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0013","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/all.13496","article-title":"Precision medicine in united airways disease: a \u201ctreatable traits\u201d approach","volume":"73","author":"Yii","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2026.08.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agust\u00ed","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2026.08.004_bib0016","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/thoraxjnl-2014-205507","article-title":"The path to personalised medicine in COPD","volume":"69","author":"Agusti","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.pccm.2026.08.004_bib0017","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","volume":"6","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0018","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis: a European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prrv.2010.10.011","article-title":"Pathogenesis of bronchiectasis","volume":"12","author":"King","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0020","first-page":"6","article-title":"Inflammation: a two-edged sword \u2013 the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"10.1016\/j.pccm.2026.08.004_bib0021","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0022","article-title":"Retrospective cross-sectional study on bronchiectasis in adult aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry cohorts","volume":"12","author":"Heraganahally","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0023","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/resp.14059","article-title":"Characteristics of bronchiectasis in Korea: first data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries","volume":"26","author":"Lee","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0024","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2026.08.004_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rmed.2019.07.016","article-title":"Australian adults with bronchiectasis: the first report from the Australian Bronchiectasis Registry","volume":"155","author":"Visser","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0026","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2213-2600(24)00364-3","article-title":"Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study","volume":"13","author":"Xu","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0027","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaci.2024.01.027","article-title":"Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC)","volume":"153","author":"Polverino","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pccm.2026.08.004_bib0028","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis Registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0029","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.pccm.2026.08.004_bib0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0015-2023","article-title":"Basic, translational and clinical aspects of bronchiectasis in adults","volume":"32","author":"Chalmers","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.pccm.2026.08.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00745-2025","article-title":"European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia","volume":"66","author":"Shoemark","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0038-2024","article-title":"Infection and the microbiome in bronchiectasis","volume":"33","author":"Mac Aog\u00e1in","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0036","article-title":"Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.pccm.2026.08.004_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0974-777X.150885","article-title":"Influence of Pseudomonas aeruginosa on exacerbation in patients with bronchiectasis","volume":"7","author":"Chawla","year":"2015","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00162-2017","article-title":"Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis","volume":"4","author":"Woo","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106275","article-title":"Global genomic diversity of Pseudomonas aeruginosa in bronchiectasis","volume":"89","author":"Harrington","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.pccm.2026.08.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01514-25","article-title":"Genomic diversity and adaptive resistance mechanisms in Pseudomonas aeruginosa from bronchiectasis","volume":"11","author":"Xiao","year":"2026","journal-title":"MSystems"},{"key":"10.1016\/j.pccm.2026.08.004_bib0041","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2019.06.012","article-title":"Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis","volume":"154","author":"Alcaraz-Serrano","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0042","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1128\/IAI.73.11.7151-7160.2005","article-title":"Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by toll-like receptor 5","volume":"73","author":"Zhang","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.pccm.2026.08.004_bib0043","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00769-2020","article-title":"Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis","volume":"56","author":"Oriano","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0044","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00938-2023","article-title":"A phase 4 multicentre, 2\u00d72 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE","volume":"10","author":"Gao","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0046","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","article-title":"A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection","volume":"163","author":"Guan","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2026.08.004_bib0047","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-2600(24)00225-X","article-title":"Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months","volume":"12","author":"Haworth","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and meta-analysis","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2026.08.004_bib0049","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/all.16687","article-title":"Fungal-driven airways dis-immunity from asthma to allergic bronchopulmonary aspergillosis: dissecting similarities and differences. An EAACI task force report","volume":"80","author":"Caminati","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2026.08.004_bib0050","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1111\/all.15820","article-title":"Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-factor analysis","volume":"78","author":"Okada","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2026.08.004_bib0051","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.chest.2024.06.3843","article-title":"Aspergillus serologic findings and clinical outcomes in patients with bronchiectasis: data from the European bronchiectasis registry","volume":"167","author":"Pollock","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2026.08.004_bib0052","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.201807-1355OC","article-title":"Distinct \u201cimmunoallertypes\u201d of disease and high frequencies of sensitization in non-cystic fibrosis bronchiectasis","volume":"199","author":"Mac Aog\u00e1in","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0053","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-2600(24)00176-0","article-title":"Rethinking bronchiectasis as an inflammatory disease","volume":"12","author":"Long","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0054","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1183\/13993003.00148-2015","article-title":"A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis","volume":"46","author":"De Soyza","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood neutrophils are reprogrammed in bronchiectasis","volume":"198","author":"Bedi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0056","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01050-2024","article-title":"Targeting neutrophil serine proteases in bronchiectasis","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0058","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0059","article-title":"NLRP3 Inflammasome activation modulates neutrophil extracellular trap formation and aggravates airway inflammation in bronchiectasis","volume":"8","author":"Chen","year":"2025","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.pccm.2026.08.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq4409","article-title":"A gut Eggerthella lenta-derived metabolite impairs neutrophil function to aggravate bacterial lung infection","volume":"17","author":"Wang","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0061","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.21037\/jtd-2025-289","article-title":"Dipeptidyl peptidase 1 inhibitors and neutrophilic inflammation in bronchiectasis: a narrative review","volume":"17","author":"Tang","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0062","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0063","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ajrccm\/aamag096","article-title":"A new anti-inflammatory treatment for bronchiectasis: A viewpoint on optimal dose selection for DPP1 inhibition in clinical practice","volume":"212","author":"Chalmers","year":"2026","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.pccm.2026.08.004_bib0064","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0065","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/thorax-2025-223305","article-title":"Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study","volume":"81","author":"Pollock","year":"2026","journal-title":"Thorax"},{"key":"10.1016\/j.pccm.2026.08.004_bib0066","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"2018","author":"Kapur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0067","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/thorax-2024-221825","article-title":"Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)","volume":"80","author":"Pollock","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.pccm.2026.08.004_bib0068","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40265-026-02294-1","article-title":"Mucus as a treatable trait in chronic airway diseases","volume":"86","author":"Cazzola","year":"2026","journal-title":"Drugs"},{"key":"10.1016\/j.pccm.2026.08.004_bib0069","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"Hill","year":"2022","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0071","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.202306-1093OC","article-title":"Proximal and distal bronchioles contribute to the pathogenesis of non-cystic fibrosis bronchiectasis","volume":"209","author":"Asakura","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0072","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01966-2023","article-title":"Airway IL-1\u03b2 is related to disease severity and mucociliary function in bronchiectasis","volume":"64","author":"Perea","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0073","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","article-title":"Hypertonic saline or carbocisteine in bronchiectasis","volume":"393","author":"Bradley","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0074","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O\u2019Donnell","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2026.08.004_bib0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2213-2600(23)00226-6","article-title":"Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial","volume":"12","author":"Ringshausen","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0076","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421915122","article-title":"Inhaled DNAI1 mRNA therapy for treatment of primary ciliary dyskinesia","volume":"122","author":"Hennig","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Supplement_2","key":"10.1016\/j.pccm.2026.08.004_bib0077","doi-asserted-by":"crossref","DOI":"10.1093\/ajrccm\/aamag286.098","article-title":"A76-28 Safety and bronchoscopy evaluation of an inhaled mRNA treatment for primary ciliary dyskinesia due to disease causing DNA variants in the DNAI1 gene: phase 1a single-dose and phase 1b multiple-dose open-label trials","volume":"212","author":"Loebinger","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0078","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0079","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251390086","article-title":"Screening and impact of comorbidities in bronchiectasis: a forward-looking perspective","volume":"19","author":"De Angelis","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0081","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032537","article-title":"Mortality and comorbidities in patients with bronchiectasis over a 3-year follow-up","volume":"101","author":"Mateus","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pccm.2026.08.004_bib0082","doi-asserted-by":"crossref","DOI":"10.1177\/14799731241310897","article-title":"Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis","volume":"22","author":"Shoaib","year":"2025","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196417","article-title":"Bronchiectasis-COPD overlap syndrome: role of peripheral eosinophil count and inhaled corticosteroid treatment","volume":"12","author":"Oscullo","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0084","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","article-title":"Asthma and bronchiectasis exacerbation","volume":"47","author":"Mao","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0085","doi-asserted-by":"crossref","DOI":"10.4168\/aair.2025.17.2.196","article-title":"The phenotypes of asthma-bronchiectasis overlap: clinical characteristics and outcomes","volume":"17","author":"Lin","year":"2025","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0086","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-208188","article-title":"Bronchiectasis and the risk of cardiovascular disease: a population-based study","volume":"72","author":"Navaratnam","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.pccm.2026.08.004_bib0087","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/resp.13298","article-title":"Increased risk of acute coronary syndrome in patients with bronchiectasis: a population-based cohort study","volume":"23","author":"Hung","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0088","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12890-020-1137-7","article-title":"Clinical impact of cardiovascular disease on patients with bronchiectasis","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0089","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01695-2022","article-title":"The impact of depression and anxiety on the risk of exacerbation in adults with bronchiectasis: a prospective cohort study","volume":"61","author":"Gao","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00348-2024","article-title":"Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort","volume":"11","author":"De Soyza","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0091","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1590\/S1807-59322009001200004","article-title":"Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis","volume":"64","author":"Pereira","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.pccm.2026.08.004_bib0092","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.iac.2020.03.003","article-title":"Chronic lung disease in primary antibody deficiency: diagnosis and management","volume":"40","author":"Maglione","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.pccm.2026.08.004_bib0093","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2249.2002.01974.x","article-title":"Humoral immunity and bronchiectasis","volume":"130","author":"Stead","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pccm.2026.08.004_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105465","article-title":"Association of short-term exposure to ambient air pollution and temperature with bronchiectasis mortality: a nationwide time-stratified case-crossover study","volume":"110","author":"Hu","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pccm.2026.08.004_bib0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/rccm.202402-0466RL","article-title":"The impact of tobacco smoking in bronchiectasis: data from the U.S. bronchiectasis and nontuberculous mycobacteria research registry","volume":"210","author":"McShane","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0096","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and genomics of bronchiectasis","volume":"33","author":"Perea","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0097","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00611-2022","article-title":"Clinical outcomes of bronchiectasis in India: data from the EMBARC\/Respiratory Research Network of India registry","volume":"61","author":"Dhar","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0098","doi-asserted-by":"crossref","DOI":"10.1177\/14799731251408842","article-title":"Implementation of the treatable traits approach in a regional clinic: improving health outcomes in adults with bronchiectasis","volume":"23","author":"Krieg","year":"2026","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0099","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5588\/ijtld.22.0489","article-title":"Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts","volume":"27","author":"Kwok","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.pccm.2026.08.004_bib0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.pccm.2026.08.004_bib0101","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1164\/rccm.201308-1404PP","article-title":"Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease","volume":"188","author":"Agust\u00ed","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0102","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/resp.12746","article-title":"Should we treat obesity in COPD? The effects of diet and resistance exercise training","volume":"21","author":"McDonald","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/resp.14758","article-title":"Treatable traits-where we are, where we are headed","volume":"29","author":"McDonald","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/resp.14644","article-title":"Treatable traits models of care","volume":"29","author":"McDonald","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/17476348.2023.2241357","article-title":"Personalised management and supporting individuals to live with their asthma in a primary care setting","volume":"17","author":"Pinnock","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0106","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/resp.14760","article-title":"Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease","volume":"29","author":"Dharmage","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0107","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-2600(15)00243-X","article-title":"PBB: definition, mechanisms, and treatment","volume":"3","author":"Chang","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0108","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02139-2016","article-title":"ERS statement on protracted bacterial bronchitis in children","volume":"50","author":"Kantar","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0109","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/resp.13950","article-title":"Outcomes of protracted bacterial bronchitis in children: a 5-year prospective cohort study","volume":"26","author":"Ruffles","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.pccm.2026.08.004_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202404-0764ED","article-title":"Reversal of bronchiectasis in children: early intervention may stop the vicious circle!","volume":"210","author":"Burgel","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pccm.2026.08.004_bib0111","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01689-2023","article-title":"Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)","volume":"63","author":"Spinou","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0112","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0113","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0234-2023","article-title":"Biomarkers in bronchiectasis","volume":"33","author":"Johnson","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0114","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00408-017-0038-x","article-title":"The objective assessment of cough frequency in bronchiectasis","volume":"195","author":"Spinou","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.pccm.2026.08.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0116","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0117","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00388-2021","article-title":"Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients","volume":"8","author":"Aliberti","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.pccm.2026.08.004_bib0119","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01769-2023","article-title":"Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype\u2013phenotype correlations","volume":"64","author":"Raidt","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0120","article-title":"Prevalence of bronchiectasis in inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Ma","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pccm.2026.08.004_bib0121","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00311-2025","article-title":"The role of screening for connective tissue diseases in bronchiectasis: an observational study","volume":"11","author":"Stainer","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0122","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1016\/j.clnu.2021.07.032","article-title":"Nutritional status and intake in patients with non-cystic fibrosis bronchiectasis (NCFB) \u2013 a cross sectional study","volume":"40","author":"King","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.pccm.2026.08.004_bib0123","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00190-2019","article-title":"Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review","volume":"6","author":"McDonnell","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0124","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.01032-2023","article-title":"The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis","volume":"10","author":"Gramegna","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.01087-2024","article-title":"Bronchiectasis and sinonasal diseases: a narrative review","volume":"11","author":"Simonetta","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pccm.2026.08.004_bib0126","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0087-2024","article-title":"Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects","volume":"33","author":"Spinou","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pccm.2026.08.004_bib0127","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02557-2017","article-title":"The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis","volume":"52","author":"Goeminne","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2026.08.004_bib0128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17476348.2024.2369716","article-title":"The impact of smoking on bronchiectasis and its comorbidities","volume":"18","author":"de la Rosa-Carrillo","year":"2024","journal-title":"Expert Rev Respir Med"}],"container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558826000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558826000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:11:12Z","timestamp":1790889072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772558826000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2772558826000496"],"URL":"https:\/\/doi.org\/10.1016\/j.pccm.2026.08.004","relation":{},"ISSN":["2772-5588"],"issn-type":[{"value":"2772-5588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable traits-based management of bronchiectasis: moving from theory to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Journal Pulmonary and Critical Care Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pccm.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}